CIK 0001427925 · Non-accelerated filer<br>Smaller reporting company
TALPHERA, INC.
Sign in to watch- Ticker
- TLPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 412193603
- Phone
- 650-216-3500
- Business address
- 1850 GATEWAY DRIVE, SUITE 175, SAN MATEO, CA, 94404
- Former names
- ACELRX PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-22 | JAIN ABHINAV Director | Grant or award | +871 | 871 | ||
| 2024-01-22 | JAIN ABHINAV Director | Grant or award · Stock Option (Right to Buy) | +5,228 | 5,228 | ||
| 2023-12-13 | Angotti Vincent J. Chief Executive Officer | Purchase | +10,000 | $0.73 | $7K | 101,805 |
| 2023-10-10 | HOFFMAN STEPHEN J Director | Grant or award | +581 | 2,418 | ||
| 2023-10-10 | HOFFMAN STEPHEN J Director | Grant or award · Stock Option (Right to Buy) | +3,487 | 3,487 | ||
| 2023-10-10 | Afable Richard Director | Grant or award | +581 | 2,468 | ||
| 2023-10-10 | Afable Richard Director | Grant or award · Stock Option (Right to Buy) | +3,487 | 3,487 | ||
| 2023-10-10 | WAN MARK A Director | Grant or award | +581 | 2,418 | ||
| 2023-10-10 | WAN MARK A Director | Grant or award · Stock Option (Right to Buy) | +3,487 | 3,487 | ||
| 2023-10-10 | Bozilenko Marina Director | Grant or award | +581 | 2,606 | ||
| 2023-10-10 | Bozilenko Marina Director | Grant or award · Stock Option (Right to Buy) | +3,487 | 3,487 | ||
| 2023-10-10 | Broadfoot Jill Marie Director | Grant or award | +581 | 2,106 | ||
| 2023-10-10 | Broadfoot Jill Marie Director | Grant or award · Stock Option (Right to Buy) | +3,487 | 3,487 | ||
| 2023-10-10 | Rosen Howard B Director | Grant or award | +581 | 5,293 | ||
| 2023-10-10 | Rosen Howard B Director | Grant or award · Stock Option (Right to Buy) | +3,487 | 3,487 | ||
| 2023-10-10 | ADAMS ADRIAN Director | Grant or award | +581 | 11,168 | ||
| 2023-10-10 | ADAMS ADRIAN Director | Grant or award · Stock Option (Right to Buy) | +3,487 | 3,487 | ||
| 2023-09-11 | Angotti Vincent J. Chief Executive Officer | Purchase | +10,000 | $0.80 | $8K | 91,805 |
| 2023-08-25 | Palmer Pamela P Chief Medical Officer | Sale | −7,442 | $1.09 | $8K | 30,753 |
| 2023-08-24 | Palmer Pamela P Chief Medical Officer | Sale | −9,514 | $1.17 | $11K | 38,195 |
Page 7 of 9 · 179 trades